Kobayashi Pharmaceutical Co., Ltd.

TSE:4967.T

5289 (JPY) • At close June 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Assets:
Current Assets:
Cash & Cash Equivalents 50,87371,53696,23395,02478,25375,58074,45664,99028,32261,42858,44951,74845,86242,83531,96332,67022,81417,16418,09124,43619,035
Short Term Investments 14,8728,3008,30014,02216,08514,9778,3008,30035,3504,5004,5003,7031,50611,00411,00510,0066,0005,7993,7951,5021,000
Cash and Short Term Investments 65,74579,836104,533109,04694,33890,55782,75673,29063,67365,92862,94955,45147,36853,83942,96842,67628,81422,96321,88625,93820,035
Net Receivables 49,38452,98447,85355,14752,82954,77353,25549,99847,000035,92334,37230,76032,04429,51826,31427,34226,22851,15447,13343,490
Inventory 24,16322,08117,67815,10714,13915,08613,64313,28912,80513,95112,48410,53111,19712,01110,89411,44612,81812,35219,84617,52315,783
Other Current Assets 5,1763,4302,8282,5892,9192,6305,4045,7695,1681,6084,6345,2605,0284,6445,4574,7724,1984,5269,2168,3127,396
Total Current Assets 144,468158,331172,892181,889164,225162,712155,058142,346128,646120,347115,990105,61494,353102,53888,83785,20873,17266,069102,10298,90686,704
Non-Current Assets:
Property, Plant & Equipment, Net 67,44847,66534,77822,52420,82121,18019,02418,24717,83317,18716,02314,94513,73013,62814,15614,77917,61715,23522,27922,78825,002
Goodwill 9,2609,6557,1477,1897,2841,5823,2412,6264,7293,5424,0233,9703,6373,5924,0216,3167,68210,67511,8703,6494,247
Intangible Assets 11,41411,9596,1605,4695,5101,5301,5822,1722,4941,7921,5591,4561,4551,6921,8982,1292,3592,1262,7312,8692,627
Goodwill and Intangible Assets 20,67421,61413,30712,65812,7943,1124,8234,7987,2235,3345,5825,4265,0925,2845,9198,44510,04112,80114,6016,5186,874
Long Term Investments 28,42135,93420,20915,44418,38924,55637,61638,49743,28435,15637,08035,17436,38511,2309,3598,10212,32618,87814,17014,1077,758
Tax Assets 3,0872,6471,7501,4891,4432,0285945393833213188383241,3022,3342,7253,2499841,7672,2912,329
Other Non-Current Assets 1,1551,28212,88818,54720,69219,80713,87014,4013,86510,64911,3348,9187,22013,90813,75112,7138,8058,4429,6367,3355,962
Total Non-Current Assets 120,900109,14282,93270,66274,13970,68375,92776,48272,58868,64770,33765,30162,75145,35245,51946,76452,03856,34062,45353,03947,925
Total Assets 265,368267,473255,827252,554238,366233,398230,989218,831201,234188,997186,331170,919157,106147,890134,356131,972125,210122,409164,555151,945134,629
Liabilities & Equity:
Current Liabilities:
Account Payables 8,26417,3059,0519,2937,5587,9798,7068,27916,0187,14110,23911,36811,57712,82312,31327,31714,99514,80012,43711,95010,321
Short Term Debt 3433792611701832095592492482471221642663964872,4721,1097263,2051,3712,692
Tax Payables 2,2594,0594,9084,4755,7886,1865,6105,8993,6012,5394,6674,2724,6334,8792,7444,0534,9934,2075,0995,2924,173
Deferred Revenue 00028,14829,55334,017034,4263,60120,45420,59621,16821,0408,0256,5047,4428,1257,20758,56756,59549,584
Other Current Liabilities 35,55734,36837,58936,76536,57839,05940,34039,84723,50726,55420,862-2,756-3,03919,69318,9815,18218,73718,20756,28753,42747,821
Total Current Liabilities 46,42356,11151,80950,70350,10753,43355,21554,27446,97536,48135,89034,21634,47737,79134,52539,02439,83437,94077,02872,04065,007
Non-Current Liabilities:
Long Term Debt 5036085314605056822,5115271,0476185136091634838741,1491,6850207261341
Deferred Revenue Non-Current 0002,0191,9602,1413,9422,9235814,5945,6130000000000
Deferred Tax Liabilities Non-Current 1,5542,5941,3101,5641,3572,7794,8515,2243,8413,1842,6830000000000
Other Non-Current Liabilities 3,4183,3444,2782,2091,8551,7062,3012,0736,0512,0972,0239,1437,5967,7377,6157,1967,3277,28716,2999,9168,619
Total Non-Current Liabilities 5,4756,5466,1196,2525,6777,3089,52710,74710,93910,49310,8329,7527,7598,2208,4898,3459,0127,28716,50610,1778,960
Total Liabilities 51,89862,65757,92856,95555,78460,74164,74265,02157,91446,97446,72243,96842,23646,01143,01447,36948,84645,22793,53482,21773,967
Equity:
Preferred Stock 000000000000000000000
Common Stock 3,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,450
Retained Earnings 208,240205,681194,285200,534187,071173,650159,857146,758147,901137,486127,858118,731109,946101,12792,18585,55278,67872,12966,77560,08653,585
Accumulated Other Comprehensive Income/Loss 019,92714,12411,0857,64211,13710,52211,6778,09701,4625,2581,95800000000
Other Total Stockholders Equity 1,776-24,242-13,960-19,523-15,580-15,5802,940-8,076-16,1281,012-1,988-488-484-2,698-4,305-4,411-5,776983-2,0107111,852
Total Shareholders Equity 213,466204,816197,899195,599182,582172,657166,247153,810143,320141,948139,587126,951114,870101,87991,33084,59176,35277,16668,21566,81160,116
Total Equity 213,470204,816197,899195,599182,582172,657166,247153,810143,395142,023139,609126,951114,870101,87991,34284,60376,36477,18271,02169,72860,662
Total Liabilities & Shareholders Equity 265,368267,473255,827252,554238,366233,398230,989218,831201,234188,997186,331170,919157,106147,890134,356131,972125,210122,409164,555151,945134,629